BioRestorative Therapies Short Interest Ratio and Short Volume

BioRestorative Therapies (OTCMKTS:BRTX) Short Interest Frequently Asked Questions

What is BioRestorative Therapies' current short interest?

Short interest is the volume of BioRestorative Therapies shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 1,000 shares of BRTX short. Learn More on BioRestorative Therapies' current short interest.

Is BioRestorative Therapies' short interest increasing or decreasing?

BioRestorative Therapies saw a increase in short interest in September. As of September 30th, there was short interest totaling 1,000 shares, an increase of 900.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does BioRestorative Therapies' short interest compare to its competitors?

0.00% of BioRestorative Therapies' shares are currently sold short. Here is how the short interest of companies in the industry of "miscellaneous health & allied services, not elsewhere classified" compare to BioRestorative Therapies: Fresenius Medical Care AG & Co. KGaA (0.00%), DaVita Inc. (2.70%), agilon health, inc. (3.16%), Progyny, Inc. (7.76%), Tivity Health, Inc. (13.66%), Convey Holding Parent, Inc. (2.94%), Global Cord Blood Co. (0.67%), Viemed Healthcare, Inc. (4.08%), Viemed Healthcare, Inc. (4.08%), and SOC Telemed, Inc. (3.30%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short BioRestorative Therapies stock?

Short selling BRTX is an investing strategy that aims to generate trading profit from BioRestorative Therapies as its price is falling. To short BioRestorative Therapies stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that BioRestorative Therapies will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioRestorative Therapies?

A short squeeze for BioRestorative Therapies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BRTX, which in turn drives the price of the stock up even further.

How often is BioRestorative Therapies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BRTX, twice per month. The most recent reporting period available is September, 30 2021.